HISTAMINE PHOSPHATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Histamine Phosphate, and when can generic versions of Histamine Phosphate launch?
Histamine Phosphate is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in HISTAMINE PHOSPHATE is histamine phosphate. There is one drug master file entry for this compound. Additional details are available on the histamine phosphate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HISTAMINE PHOSPHATE?
- What are the global sales for HISTAMINE PHOSPHATE?
- What is Average Wholesale Price for HISTAMINE PHOSPHATE?
Summary for HISTAMINE PHOSPHATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Clinical Trials: | 1 |
| Patent Applications: | 401 |
| DailyMed Link: | HISTAMINE PHOSPHATE at DailyMed |
Recent Clinical Trials for HISTAMINE PHOSPHATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Kuopio University Hospital | N/A |
Medical Subject Heading (MeSH) Categories for HISTAMINE PHOSPHATE
Anatomical Therapeutic Chemical (ATC) Classes for HISTAMINE PHOSPHATE
US Patents and Regulatory Information for HISTAMINE PHOSPHATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | HISTAMINE PHOSPHATE | histamine phosphate | INJECTABLE;INJECTION | 000734-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lilly | HISTAMINE PHOSPHATE | histamine phosphate | INJECTABLE;INJECTION | 000734-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lilly | HISTAMINE PHOSPHATE | histamine phosphate | INJECTABLE;INJECTION | 000734-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
